Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Matinas BioPharma is a biotechnology business based in the US. Matinas BioPharma stocks (MTNB.US) are listed on the NYSE MKT and all prices are listed in US Dollars. Its last market close was $0.7424 – a decrease of 6.43% over the previous week. Matinas BioPharma employs 34 staff and has a trailing 12-month revenue of around $4.3 million.
National Bank Direct Brokerage
Finder Award
Interactive Brokers
| Latest market close | $0.39 |
|---|---|
| 52-week range | $0.39 - $0.94 |
| 50-day moving average | $0.50 |
| 200-day moving average | $0.60 |
| Wall St. target price | $2.17 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.09 |
Note: The dollar amounts in the table below are in Canadian dollars.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of $0.393 from 2023-06-01
| 1 week (2023-05-26) | -6.43% |
|---|---|
| 1 month (2023-05-03) | -33.50% |
| 3 months (2023-03-03) | -21.08% |
| 6 months (2022-12-02) | -40.90% |
| 1 year (2022-06-03) | -52.42% |
|---|---|
| 2 years (2021-06-03) | -52.54% |
| 3 years (2020-06-03) | 0.859 |
| 5 years (2018-06-01) | 0.5958 |
| Revenue TTM | $4.3 million |
|---|---|
| Gross profit TTM | $-13,490,000 |
| Return on assets TTM | -29.84% |
| Return on equity TTM | -51.13% |
| Profit margin | 0% |
| Book value | $0.15 |
| Market capitalisation | $92.2 million |
TTM: trailing 12 months
We're not expecting Matinas BioPharma to pay a dividend over the next 12 months.
Over the last 12 months, Matinas BioPharma's shares have ranged in value from as little as $0.389 up to $0.94. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while Matinas BioPharma's is 2.0246. This would suggest that Matinas BioPharma's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Matinas BioPharma Holdings, Inc. , a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides. Its lead product candidate is LYPDISO, a prescription-only omega-3 fatty acid-based composition intended for the treatment of cardiovascular and metabolic conditions. The company also offers MAT2203, an oral formulation of amphotericin B that is in Phase II clinical trials for the prevention of invasive fungal infections due to immunosuppressive therapy in patients. In addition, it provides MAT2501, an orally administered formulation of the broad-spectrum aminoglycoside antibiotic amikacin that has completed Phase I clinical trials to treat various types of multidrug-resistant bacteria, including non-tuberculous mycobacterium infections, as well as various multidrug-resistant gram negative and intracellular bacterial infections.
Your guide to how ETFs work and whether this type of investment is right for you.
Read more…
The best stock trading app for beginners is easy to use and offers free trades.
Read more…
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
Read more…From personal and payday loans to lines of credit, compare loans for bad credit in Edmonton.
This guide provides step-by-step instructions on how to buy Sui, lists some exchanges where you can get it and provides daily price data on (SUI).
This guide provides step-by-step instructions on how to buy Pepe, lists some exchanges where you can get it and provides daily price data on (PEPE).
This guide provides step-by-step instructions on how to buy Arbitrum, lists some exchanges where you can get it and provides daily price data on (ARB).
This guide provides step-by-step instructions on how to buy SSV Network, lists some exchanges where you can get it and provides daily price data on (SSV).
This guide provides step-by-step instructions on how to buy USDD, lists some exchanges where you can get it and provides daily price data on (USDD).
This guide provides step-by-step instructions on how to buy Blur, lists some exchanges where you can get it and provides daily price data on (BLUR).
This guide provides step-by-step instructions on how to buy FLOKI Inu, lists some exchanges where you can get it and provides daily price data on (FLOKI).
This guide provides step-by-step instructions on how to buy Aptos, lists some exchanges where you can get it and provides daily price data on (APT).
This guide provides step-by-step instructions on how to buy EthereumPoW, lists some exchanges where you can get it and provides daily price data on (ETHW).
